Androgen Receptor Gene Polymorphism and Polycystic Ovary Syndrome

    November 2012
    Lawrence Hsu Lin, Maria Cândida Pinheiro Baracat, Gustavo Arantes Rosa Maciel, José Maria Soares, Edmund Chada Baracat
    Image of study
    TLDR The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.
    The document reviewed the potential link between androgen receptor (AR) gene polymorphism and polycystic ovary syndrome (PCOS), analyzing 10 studies with a total of 1508 PCOS patients and 1623 controls. It found that three studies reported a correlation between AR gene polymorphism and PCOS, with two indicating an association with shorter CAG repeats and one with longer repeats. However, due to methodological differences and insufficient data for a meta-analysis, the review concluded that while AR gene polymorphism could be a promising biomarker for PCOS, more research with larger, more consistent study designs is necessary to clarify this relationship.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community Maintaining hair until Breezula without Fin

      in Treatment  6 upvotes 4 years ago
      A 21-year-old male experienced side effects from topical finasteride and is seeking alternative treatments to maintain hair until Breezula is available. He is considering using minoxidil, Nizoral, micro-needling, and vitamin D supplementation, and may try CB or RU58841 if necessary.

      community Binding affinity of pyrilutamide!

      in Update  167 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community Hair loss causes are still a myth.

      in Chat  16 upvotes 3 years ago
      The conversation discusses the complexity of hair loss causes, suggesting that DHT sensitivity alone doesn't fully explain it. Treatments mentioned include finasteride and dutasteride.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  122 upvotes 1 year ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

    Related Research

    4 / 4 results